Solvay sells North American and European amphoteric surfactants business

6-Jan-2021

The purchase by private equity firm OpenGate Capital includes the company’s three main production sites for amphoterics

Solvay sells North American and European amphoteric surfactants business

Brussels-based science company The Solvay Group has inked a deal to sell its North American and European amphoteric surfactants business to OpenGate Capital, a Los Angeles private equity firm.

The sale includes the three main production sites supporting Solvay’s amphoteric product lines – University Park, Illinois (US), Genthin, Germany and Halifax, UK – as well as a tolling business in Turkey.

Sign up for your free email newsletter

The sale, said Solvay, would generate additional resources for it to invest in strategic growth segments as part of its portfolio simplification journey.

Companies